semaglutide 7.2 mg clinical trial Efficacy and safety of once-weekly 2·0 versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B New Science Suggests Semaglutide Improves

At Wellness Solutions, we are always looking for elevated, science-backed approaches to holistic wellness

As mentioned earlier, Noom Med connects you to a licensed clinician who can assess your health history and determine if prescription GLP-1s or weight-loss medications are right for you

Our Red Light and Near Infrared (NIR) Therapy offers a non-invasive solution to enhance fat loss , reduce inflammation , and promote skin rejuvenation

4.6.2 Retinal disease Diabetic retinopathy (DR) is the most prevalent microvascular complication of diabetes and the leading cause of preventable blindness among working-age individuals (81)